Evidence map›Paper›PMID 37763310›Full record

ArticleLife (Basel, Switzerland)2023

Exploring Small-Diameter Melanomas: A Retrospective Study on Clinical and Dermoscopic Features.

Maria Fernanda Vianna Hunziker, Beatrice Martinez Zugaib Abdalla, Flavia Vieira Brandão, Luana Pizarro Meneghello, Jaciara Moreira Sodré Hunnicutt, Thais Helena Bello Di Giacomo, Cristina Martinez Zugaib Abdalla, Ana Maria Fagundes Sortino

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Maria Fernanda Vianna HunzikerHospital Sirio Libanês, Rua Dona Adma Jafet, 115, Bela Vista, São Paulo 01308-050, SP, Brazil.
Beatrice Martinez Zugaib AbdallaHospital Sirio Libanês, Rua Dona Adma Jafet, 115, Bela Vista, São Paulo 01308-050, SP, Brazil.
Flavia Vieira BrandãoDermatology Department, Hospital Regional da Asa Norte, SMHN Quadra 101 Bloco A Área Especial, Brasília 70710-905, DF, Brazil.
Luana Pizarro MeneghelloUniversidade Franciscana, Rua Silva Jardim, 1175, Conjunto III, Prédio 17, Sala 809, Santa Maria 97010-491, RS, Brazil.
Jaciara Moreira Sodré HunnicuttHospital Sirio Libanês, Rua Dona Adma Jafet, 115, Bela Vista, São Paulo 01308-050, SP, Brazil.
Thais Helena Bello Di GiacomoHospital Sirio Libanês, Rua Dona Adma Jafet, 115, Bela Vista, São Paulo 01308-050, SP, Brazil.
Cristina Martinez Zugaib AbdallaHospital Sirio Libanês, Rua Dona Adma Jafet, 115, Bela Vista, São Paulo 01308-050, SP, Brazil.
Ana Maria Fagundes SortinoHospital Sirio Libanês, Rua Dona Adma Jafet, 115, Bela Vista, São Paulo 01308-050, SP, Brazil.ORCID 0000-0002-4340-158X
Hospital Sírio-Libanês · BRHospital de Base · BRUniversidade Franciscana · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly melanoma detection allows for timely intervention and treatment, significantly improving the chances of favorable outcomes for patients. Small-diameter melanoma (SDM) typically represents an initial growth phase of cutaneous melanoma. One of the challenges in detecting melanoma in their early stage lies in the fact that dermoscopy criteria have been primarily designed for fully developed lesions. Early-stage melanomas may be difficult to detect and possibly even be overlooked or misinterpreted during examinations.

methodsThe primary aim of this study was to identify valuable clinical and dermoscopic clues to enhance the detection of SDMs. To achieve this objective, we conducted a comprehensive retrospective analysis, including forty SDMs with a diameter of 5 mm or less. These cases were diagnosed over an 8-year period and were collected from five referral centers across Brazil. Seven experienced dermatologists independently assessed the dermoscopic features of each lesion. Additionally, this study includes demographic and histological information.

resultsThe study encompassed a total of 28 patients, of which 16 were females, accounting for 58% of the participants, with an average age of 43.6 years. Among the small-diameter melanomas (SDMs) under investigation, the majority, constituting 27 cases (69.2%), were identified as "de novo" lesions, i.e., not associated with a nevus. Additionally, eight SDMs (20%) exhibited invasive characteristics, with Breslow index measurements ranging between 0.2 to 0.4 mm, suggesting an early stage of malignancy. During dermoscopic examinations, the most prevalent features observed were irregular dots and globules, present in 95% and 87.5% of cases, respectively. Moreover, brown structureless areas were identified in 70% of lesions, followed by atypical network (67.5%), pseudopods (55%), dotted vessels (47.5%), flat structureless blue-gray areas (42.5%), and irregular blotches (40%). Notably, all SDM were diagnosed in patients under surveillance through total body skin photography (TBSP) and Digital Dermoscopy (DD).

conclusionsDermoscopy significantly enhances the diagnostic accuracy of melanoma, even in its early stages. Particularly for high-risk patients with numerous nevi, the identification of a new lesion or subtle changes on dermoscopy during follow-up may serve as the sole clue for an early diagnosis. This emphasizes the critical role of dermoscopy in SDM detection and reinforces the importance of surveillance in high-risk patients for timely and effective management.

Indexed as

dermoscopymelanomamicro-melanomamini-melanomasmall-diameter melanoma

Identifiers

PMID37763310
PMCPMC10533118
OpenAlexW4386744874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.